Ritodrine‐induced rhabdomyolysis, infantile myotonic dystrophy, and maternal myotonic dystrophy unveiled
Sign Up to like & getrecommendations! Published in 2017 at "Journal of Obstetrics and Gynaecology Research"
DOI: 10.1111/jog.13211
Abstract: A primiparous pregnant woman in remission of myositis suffered very acute‐onset ritodrine‐induced rhabdomyolysis. At 29 gestational weeks, ritodrine was administered for threatened preterm labor. Just 3 h later, she complained of severe limb muscle pain,… read more here.
Keywords: induced rhabdomyolysis; ritodrine induced; myotonic dystrophy; ritodrine ... See more keywords
Identifying genetic variants associated with ritodrine-induced pulmonary edema
Sign Up to like & getrecommendations! Published in 2020 at "PLoS ONE"
DOI: 10.1371/journal.pone.0241215
Abstract: Introduction Ritodrine is one of the most commonly used tocolytics in preterm labor, acting as a ß2-adrenergic agonist that reduces intracellular calcium levels and prevents myometrial activation. Ritodrine infusion can result in serious maternal complications,… read more here.
Keywords: genetic variants; induced pulmonary; pulmonary edema; edema ... See more keywords
Associations of GNAS and RGS Gene Polymorphisms with the Risk of Ritodrine-Induced Adverse Events in Korean Women with Preterm Labor: A Cohort Study
Sign Up to like & getrecommendations! Published in 2022 at "Pharmaceutics"
DOI: 10.3390/pharmaceutics14061220
Abstract: Ritodrine, a β2-adrenergic receptor agonist, is among most commonly prescribed tocolytic agents. This study aimed to evaluate the associations of single nucleotide polymorphisms in GNAS, RGS2, and RGS5 with the risk of ritodrine-induced adverse events… read more here.
Keywords: ritodrine induced; ritodrine; induced adverse; risk ritodrine ... See more keywords